Quoin Pharmaceuticals (QNRX) Competitors $7.36 +0.19 (+2.58%) Closing price 08/14/2025 03:58 PM EasternExtended Trading$7.24 -0.13 (-1.70%) As of 08/14/2025 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock QNRX vs. IINN, OSRH, BDMD, XAIR, MHUA, DHAI, LYRA, TNON, INBS, and BTCYShould you be buying Quoin Pharmaceuticals stock or one of its competitors? The main competitors of Quoin Pharmaceuticals include Inspira Technologies OXY B.H.N. (IINN), OSR (OSRH), Baird Medical Investment (BDMD), Beyond Air (XAIR), Meihua International Medical Technologies (MHUA), DIH Holding US (DHAI), Lyra Therapeutics (LYRA), Tenon Medical (TNON), Intelligent Bio Solutions (INBS), and Biotricity (BTCY). These companies are all part of the "medical equipment" industry. Quoin Pharmaceuticals vs. Its Competitors Inspira Technologies OXY B.H.N. OSR Baird Medical Investment Beyond Air Meihua International Medical Technologies DIH Holding US Lyra Therapeutics Tenon Medical Intelligent Bio Solutions Biotricity Quoin Pharmaceuticals (NASDAQ:QNRX) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership. Is QNRX or IINN more profitable? Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Quoin Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Quoin PharmaceuticalsN/A -210.50% -99.41% Inspira Technologies OXY B.H.N. N/A N/A N/A Do institutionals & insiders have more ownership in QNRX or IINN? 8.6% of Quoin Pharmaceuticals shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 13.5% of Quoin Pharmaceuticals shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, QNRX or IINN? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuoin PharmaceuticalsN/AN/A-$8.96M-$41.45-0.18Inspira Technologies OXY B.H.N.N/AN/A-$11.05MN/AN/A Which has more risk & volatility, QNRX or IINN? Quoin Pharmaceuticals has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.3, meaning that its stock price is 130% more volatile than the S&P 500. Does the media refer more to QNRX or IINN? In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Quoin Pharmaceuticals. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 2 mentions for Quoin Pharmaceuticals. Quoin Pharmaceuticals' average media sentiment score of 1.18 beat Inspira Technologies OXY B.H.N.'s score of 0.85 indicating that Quoin Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quoin Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend QNRX or IINN? Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, indicating a potential upside of 59.36%. Given Inspira Technologies OXY B.H.N.'s stronger consensus rating and higher probable upside, analysts plainly believe Inspira Technologies OXY B.H.N. is more favorable than Quoin Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quoin Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inspira Technologies OXY B.H.N. 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryInspira Technologies OXY B.H.N. beats Quoin Pharmaceuticals on 9 of the 11 factors compared between the two stocks. Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding QNRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNRX vs. The Competition Export to ExcelMetricQuoin PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.22M$2.48B$5.61B$9.84BDividend YieldN/A1.76%4.61%4.07%P/E Ratio-0.1822.0530.2925.74Price / SalesN/A742.42469.53115.79Price / CashN/A184.4138.2159.48Price / Book1.704.838.846.15Net Income-$8.96M$31.61M$3.25B$265.06M7 Day Performance3.59%4.55%3.74%2.60%1 Month Performance-16.12%5.69%5.88%2.83%1 Year Performance-57.91%12.71%30.27%25.58% Quoin Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNRXQuoin Pharmaceuticals1.319 of 5 stars$7.37+2.6%N/A-56.3%$4.22MN/A-0.184Positive NewsGap UpIINNInspira Technologies OXY B.H.N.3.3326 of 5 stars$1.26-3.8%$2.00+58.7%+20.7%$15.91MN/A0.0020Short Interest ↓Gap DownOSRHOSRN/A$0.74+13.7%N/AN/A$14.36M-$148.95K0.00N/AEarnings ReportBDMDBaird Medical InvestmentN/A$2.02+6.9%N/AN/A$13.29MN/A0.00N/APositive NewsGap UpXAIRBeyond Air3.7183 of 5 stars$2.79-2.3%$23.67+749.8%-71.0%$12.92M$3.70M-0.1870News CoverageEarnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionMHUAMeihua International Medical Technologies0.7915 of 5 stars$0.38+0.2%N/A-39.7%$12.16M$96.91M0.00620Short Interest ↑DHAIDIH Holding US0.4989 of 5 stars$0.26+4.1%N/A-90.6%$12.12M$64.47M-0.85N/AShort Interest ↑LYRALyra Therapeutics2.993 of 5 stars$6.86+0.4%$100.00+1,357.7%-50.5%$10.90M$1.53M-0.1150News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionTNONTenon Medical2.1016 of 5 stars$1.39-1.1%$4.67+236.9%+197.9%$10.55M$3.28M-0.058News CoverageEarnings ReportShort Interest ↑Gap DownINBSIntelligent Bio Solutions0.6003 of 5 stars$1.49-2.3%N/A+31.0%$10.26M$2.94M0.0010BTCYBiotricityN/A$0.38+5.6%N/A+25.3%$9.47M$12.06M-0.3540News CoverageGap Up Related Companies and Tools Related Companies IINN Competitors OSRH Competitors BDMD Competitors XAIR Competitors MHUA Competitors DHAI Competitors LYRA Competitors TNON Competitors INBS Competitors BTCY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:QNRX) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Quoin Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access